<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01399801</url>
  </required_header>
  <id_info>
    <org_study_id>F/N-R09-284IL</org_study_id>
    <nct_id>NCT01399801</nct_id>
  </id_info>
  <brief_title>Optimizing Left Ventricular Lead To Improve Cardiac Output</brief_title>
  <acronym>CARE/VOLCANO</acronym>
  <official_title>Optimizing the Left Ventricular Contractility in Cardiac Resynchronization Therapy Using a Doppler Wire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Main Line Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Main Line Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if optimal lead placement, guided by the largest
      improvement in aortic flow measured by Doppler will:

        1. Improve the way the heart's left ventricle functions

        2. Decrease the number of hospital admissions for heart failure related symptoms

        3. Reduces uncoordinated heart contractions

        4. Improve quality of life as measured by the Minnesota Living with Heart Failure
           Questionaire and NYHA Class assessed after six months
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The hypothesis of this study determines if response to CRT therapy could be improved by
      optimizing LV lead position at the time of the left ventricular pacing lead implantation.
      This optimization (using a Doppler wire) would alter the left ventricular activation pattern
      and contraction mechanics. This increase in contractility may improve the likelihood of
      mid/long term response to therapy. This study will compare 6-month response to CRT (left
      ventricular ejection fraction, decrease in left ventricular end systolic and end diastolic
      dimensions and volumes) in heart failure patients.

      The secondary objective will be to:

        1. To determine if optimal lead placement, guided by the largest improvement in stroke
           volume, results in a greater 6-month improvement in clinical QOL and NYHA class.

        2. Acutely compare and/or correlate intra-operative A-V and V-V timing optimization via
           invasive pressure volume data to post-operative echo optimization of these same
           parameters.

        3. Acutely contrast changes in stroke volume during pacing from several different left
           ventricular lead locations.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Left Ventricular End Systolic Volume (LVESV) using the difference from baseline to six months</measure>
    <time_frame>Six months</time_frame>
    <description>Comparison of clinical and functional outcomes of stroke volume optimized lead placement to standard lateral lead placement.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in End diastolic volume</measure>
    <time_frame>Six months</time_frame>
    <description>End diastolic volume should decrease over follow up time of six months as a result of left ventricular remodeling.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in ejection fraction</measure>
    <time_frame>six months</time_frame>
    <description>Increase in ejection fraction should happen as a result of remodeling and increased efficiency of the left ventricle</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increase in exercise capacity</measure>
    <time_frame>six months</time_frame>
    <description>Inrease in exercise capacity should be result of remodeled left ventricle and increased stroke volume and cardiac output</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease in heart failure related hospital admissions</measure>
    <time_frame>six months</time_frame>
    <description>number of hospitalizations for CHF should decrease during follow up</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Ischemic Congestive Cardiomyopathy</condition>
  <condition>Dilated Cardiomyopathy</condition>
  <condition>Congestive Heart Failure</condition>
  <arm_group>
    <arm_group_label>hemodynamicaly guided LV lead placement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>optimized left ventricular lead placement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard lead placement</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard LV lead placement with no measurements to guide LV lead placement</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Doppler flow measurement</intervention_name>
    <description>use of doppler wire to measure change in flow that corresponds to changes in stroke volume to guide LV lead placement</description>
    <arm_group_label>hemodynamicaly guided LV lead placement</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>standard implantation of the LV lead</intervention_name>
    <description>Standard implantation of the LV lead with measurements of flow</description>
    <arm_group_label>Standard lead placement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical indication for CRT-P or CRT-D

          -  QRS Duration&gt;=120 MSEC

          -  Left Ventricular Ejection fraction&lt;=35%

          -  NYHA Class III-IV

          -  History of Cardiomyopathy, least one month post MI, or at least six months old in case
             of non-ischemic cardiomyopathy

          -  At least 18 years of afe

        Exclusion Criteria:

          -  Previous implanted CRT-P/CRT-D

          -  woman who are pregnant

          -  Psychological or emotional problems
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dusan Kocovic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lankenau Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dusan Kocovic, MD</last_name>
    <phone>610-649-6980</phone>
    <email>Kocovicd@mlhs.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nancy Britton, RN</last_name>
    <phone>484-476-8578</phone>
    <email>Brittonn@mlhs.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lankenau Hosspital</name>
      <address>
        <city>Wynnewood</city>
        <state>Pennsylvania</state>
        <zip>19096</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dusan Kocovic, MD</last_name>
      <phone>610-649-6980</phone>
      <email>Kocovicd@mlhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Nancy Britton, RN</last_name>
      <phone>484-476-8578</phone>
      <email>Brittonn@mlhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kocovic Dusan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2011</study_first_submitted>
  <study_first_submitted_qc>July 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2011</study_first_posted>
  <last_update_submitted>July 17, 2012</last_update_submitted>
  <last_update_submitted_qc>July 17, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 18, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Main Line Health</investigator_affiliation>
    <investigator_full_name>Dusan Kocovic, M.D.,</investigator_full_name>
    <investigator_title>Dusan Kocovic, MD</investigator_title>
  </responsible_party>
  <keyword>Cardiac Resynchronization Therapy</keyword>
  <keyword>medically refractory heart failure patients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Cardiomyopathy, Dilated</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

